The total return over the past 12 months is -48.33% vs. +16.94% for the S&P 500. So far it's up -65.66% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (48.33%) | N/A | N/A | N/A | N/A | N/A |
| Total Return CAGR | (48.33%) | N/A | N/A | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Lexeo Therapeutics, Inc. Common Stock (LXEO)
| Year | Start price | End price | LXEO Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $9.93 | $3.41 | (65.66%) | +14.51% | (80.17%) |
| 2025 | $6.58 | $9.93 | +50.91% | +17.72% | +33.19% |
| 2024 | $13.42 | $6.58 | (50.97%) | +24.89% | (75.86%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
